Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: An open-labeled study (vol 89, pg 2756, 2004)

被引：0
|
作者：
Ganie, MA
Khurana, ML
Eunice, M
Gulati, M
Dwivedi, SN
Ammini, AC
机构：
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2004年 / 89卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4655 / 4655
页数：1
相关论文
共 50 条
  • [1] Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: An open-labeled study
    Ganie, MA
    Khurana, ML
    Eunice, M
    Gulati, M
    Dwivedi, SN
    Ammini, AC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06): : 2756 - 2762
  • [2] Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
    Diri, Halit
    Karaburgu, Sulbiye
    Acmaz, Banu
    Unluhizarci, Kursad
    Tanriverdi, Fatih
    Karaca, Zuleyha
    Kelestimur, Fahrettin
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (01) : 42 - 45
  • [3] Spironolactone for hirsutism in polycystic ovary syndrome (vol 39, pg 1517, 2005)
    Christy, NA
    Franks, AS
    Cross, LB
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (10) : 1765 - 1765
  • [4] Comparison of metabolic effects of metformin and rosiglitazone in the management of polycystic ovary syndrome (PCOS): A prospective, parallel, randomized, open-label study
    Ahmad, Jamal
    Shukla, Nidhi
    Khan, Abdur Rahman
    Ahmed, Faiz
    Siddiqui, M. Asim
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2008, 2 (01) : 37 - 46
  • [5] The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial
    Haidari, Fatemeh
    Banaei-Jahromi, Nasrin
    Zakerkish, Mehrnoosh
    Ahmadi, Kambiz
    NUTRITION JOURNAL, 2020, 19 (01)
  • [6] The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial
    Fatemeh Haidari
    Nasrin Banaei-Jahromi
    Mehrnoosh Zakerkish
    Kambiz Ahmadi
    Nutrition Journal, 19
  • [7] The cardiovascular risk of young women with polycystic ovary syndrome:: An observational, analytical, prospective case-control study (vol 89, pg 3696, 2004)
    Orio, F
    Palomba, S
    Spinelli, L
    Cascella, T
    Tauchmanovà, L
    Zullo, F
    Lombardi, G
    Colao, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5621 - 5621
  • [8] Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
    Han Zhao
    Jiaqi Zhang
    Chuan Xing
    Xiangyi Cheng
    Bing He
    Journal of Ovarian Research, 17
  • [9] Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial
    Zhang, Jiaqi
    Xing, Chuan
    Cheng, Xiangyi
    He, Bing
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
    Zhao, Han
    Zhang, Jiaqi
    Xing, Chuan
    Cheng, Xiangyi
    He, Bing
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
12345